Concepedia

Jonathan Meyer

JM

Statistics

Publications

4

Citations

256

H-Index

4

Active since

1997

Affiliations

Regeneron (United States)(Current)

University of Pennsylvania

Jonathan Meyer is an author at Regeneron (United States) specializing in pharmacotherapy, immunotherapy, and immunomodulatory drug therapy.

ORCID

Publications per year

1997–2024

4

Publications

4

Prospective evaluation of fine needle aspiration of small, solid renal masses: Accuracy and morbidity

Steven C. Campbell, Andrew C. Novick, Brian R. Herts et al. · Urology · 1997 · 156 citations

, , +12

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

Gary Herman, Meagan P. O’Brien, Eduardo Forleo‐Neto et al. · The Lancet Infectious Diseases · 2022 · 41 citations · Full text

, , +8

Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19

Flonza Isa, Eduardo Forleo‐Neto, Jonathan Meyer et al. · International Journal of Infectious Diseases · 2022 · 32 citations · Full text

, , +13

Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone

Michael E. Dunn, Aaron Kithcart, Jee Hae Kim et al. · Nature · 2024 · 27 citations · Full text

, , +14

1–4 of 4